Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb. (Q40092180)
Jump to navigation
Jump to search
scientific article published on 13 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb. |
scientific article published on 13 August 2007 |
Statements
1 reference
Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb. (English)
1 reference
Betty Li
1 reference
Jianmin Lin
1 reference
Melinda Vanroey
1 reference
Maria Jure-Kunkel
1 reference
Karin Jooss
1 reference
13 August 2007
1 reference
1 reference
125
1 reference
1
1 reference
76-87
1 reference
Identifiers
1 reference
1 reference